| Page 151 | Kisaco Research

The Role of Competition Authorities within the Litigation and Licensing Landscape

Competition authorities are playing an increasingly influential role in shaping SEP and FRAND disputes worldwide. This session examines how regulators—from the European Commission to antitrust bodies in Brazil, India, and the US— are impacting injunction enforcement, licensing conduct, and broader litigation strategies. Panellists will discuss the political and consumer protection pressures driving authority interventions and how these forces interact with ongoing court cases and regulatory reforms.

• Analyse how competition authorities in Europe, Brazil, India, and the US influence injunction policies and SEP licensing practices.

• Discuss key investigations and decisions, including the European Commission’s amicus briefs and Brazilian antitrust probes into preliminary injunctions.

• Understand the evolving intersection of antitrust enforcement with SEP litigation and how it affects parties’ negotiation and enforcement strategies.

Author:

Carl-Alexander Dinges

Partner

Bonabry

Author:

Ief Daems

Associate General Counsel

Cisco

Read more about The Role of Competition Authorities within the Litigation and Licensing Landscape

AI and the Impact Upon Global Patent Litigation Strategies

Is there a technology emerging more conspicuously than AI? Probably not. This session explores how AI is impacting patenting and patent litigation considerations worldwide. Understand the evolving challenges these technologies present, how patent enforcement strategies are adapting, and the legal frameworks, including the EU AI Act and DSM Directive, influencing IP management today.

Discuss the intersection of AI development, patent creation, and prosecution, including implications of the EU AI Act and DSM Directive on IP strategy
Understand why patent litigation remains the IP function’s primary focus amid AI’s rise, and the evolving landscape of trade secrets, copyright, and trademarks
Discuss the impact of AI upon drug discovery and the inventorship considerations that companies must understand to make sure their products are litigation-proof